Acute Pain Management for Patients Maintained on Sublingual Buprenorphine as Medication for Opioid Use Disorder.

Objective: The aim of this study was to compare morphine milligram equivalent (MME) requirements for acute pain management between patients admitted for medical or surgical diagnoses with opioid use disorder (OUD) who receive >12 mg of sublingual buprenorphine daily compared with those who receive ≤12 mg/d.

Design: This study was performed via retrospective chart review.

Setting: This study evaluated patient encounters between January 2017 and November 2021 from a single-center community teaching hospital in Lancaster, PA.

Optimizing the dose of three-factor prothrombin complex concentrate in traumatic brain injury patients on warfarin therapy.

Study Objective: To determine the percentage of patients with correction of their first international normalized ratio (INR) less than 1.5 after administration of moderate-dose three-factor prothrombin complex concentrate (PCC), 35 IU/kg compared with low-dose PCC, 25 IU/kg.

Design: Retrospective review.

Effects of a pharmacist-led pediatrics medication safety team on medication-error reporting.

Purpose: The effects of a pharmacist-led pediatrics medication safety team (PMST) on the frequency and severity of medication errors reported were studied.

Methods: This study was conducted in a pediatric critical care center (PCCC) in three phases. Phase 1 consisted of retrospective collection of medication-error reports before any interventions were made.